POLDIP2 and breast carcinoma: Finally, direct and independent evidence of the TNFAIP1/POLDIP2 SFGM activation in breast cancer cells comes from the custom track for RNA polymerase II binding in the MCF7 breast cancer cell line (Figure 2B, black arrows) [44].